← Back to Patent Explorer
US4623718A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel composition of matter of antithrombin III bound to a heparin fragment

Assignee: Pfizer Health AB
•
Filing: 1983-06-10
•
Granted: 1986-11-18
•
Expires: 2003-06-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel chemical compounds which are heparin fragments with a molecular weight of from 2,000 to 5,500 covalently bound to antithrombin III, and their use in medicine.

Inventors

  • 👤 Desire J. Collen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:41
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/61; A61P; A61P7/00; A61P7/02; C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 16 words
A heparin fragment with a molecular weight of 2,000 to, 5,500 covalently bound to antithrombin III.
Claim 2
Dependent Claim 16 words
A heparin fragment with a molecular weight of 2,000 to, 5,500 covalently bound to antithrombin III.
Claim 3
Dependent Claim 22 words
The heparin fragment bound to antithrombin III of claim 1 wherein the ratio of the heparin fragments to antithrombin III is 1:1.
Claim 4
Dependent Claim 32 words
The heparin fragment bound to antithrombin III of claim 1 wherein the heparin fragment, prior to being covalently bound to the antithrombin III, contains from 1 to 2 amino groups per fragment.
Claim 5
Dependent Claim 32 words
The heparin fragment bound to antithrombin III of claim 1 wherein the heparin fragment, prior to being covalently bound to the antithrombin III, includes one terminal group which contains an aldehyde function.

References Cited (Backward Citations)

US4301153A Cited
US4213962A Cited
US4303651A Cited
US4351938A Cited
US4386025A Cited
US4446126A Cited
US4415559A Cited
US4526714A Cited
US4533549A Cited
EP0137356A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-11-17 1990-05-19 1990-11-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-11-17 1994-05-19 1994-11-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-11-17 1998-05-19 1998-11-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag